Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_assertion type Assertion NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_head.
- NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_assertion description "[And that VMAT2 protein transiently increased in acute stages (1 day and 3 days) after epileptic seizures in pilocarpine-treated rats; however, it clearly decreased after spontaneous recurrent seizures (7 days, 21 days, and 60 days after seizures).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_provenance.
- NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_assertion evidence source_evidence_literature NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_provenance.
- NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_assertion SIO_000772 23504951 NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_provenance.
- NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_assertion wasDerivedFrom befree-20140225 NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_provenance.
- NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_assertion wasGeneratedBy ECO_0000203 NP563204.RAS9Z5ccXJTyM8ENczHB2IEGZp-L8HeuIq3UjQmob8Lx0130_provenance.